Déclaration de participation
Newron Pharmaceuticals S.p.A.
Taux déclaré collectivement
22.03%
Seuil
Franchi à la hausse
Chronologie
Publication
05.11.2015
Transaction
02.11.2015
Répartition des droits
Ayants droit économique déclarés · 2
Une seule déclaration, déposée collectivement : le taux de droits de vote porte sur le groupe entier, pas sur chaque personne.
Détails de l'annonce
Identifiant de déclaration
TBFB300057
Ayant droit économique
Investor AB
Adresse déclarée
Investor AB, 10332 Stockholm
Change to the composition of the group by an indirect sale resulting from an intra-group transfer within the Investor group of the shares in Duba from Investor to Patricia Industries II. For clarification,Investor remains the beneficial owner. As of the date of this notice, the Newron shares are held dIrectly by Zambon and Duba Zambon Company S.p.A. Via Lillo del Duca n. 10,20091 - Bresso (Milan), Italy, Registry of Companies of Milan n. 01690280159 ("Zambon") is an entily controlled at 85.92% by GEFIM. Duba AB, Arsenalsgatan No. 8 C, 103 32, Stockholm, Sweden, registered number 556593-5508 ( Duba ) is (as of the date of this notice, a wholly-owned direct subsidiary of Patricia Industries II AB, 103 32 Stockholm, Sweden, registered number 556619-6811 ( Patricia Industries II ). Patricia Industries II is a wholly-owned direct subsidiary of Investor. On 21 January 2013, Zambon and Duba entered into a shareholders agreement relating to their respective stakes in Newron.
insider24.ch
Ne manquez plus aucun signal de marché
Besoin de plus ? Découvrir l'offre Pro